Related references
Note: Only part of the references are listed.Simultaneous determination of triptolide, tripterifordin, celastrol and nine sesquiterpene alkaloids in Tripterygium preparations using high-performance liquid chromatography-triple quadrupole mass spectrometry
Heng Luo et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Cellular distribution of injected PLGA-nanoparticles in the liver
Jin-Kyu Park et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers
Xiaoli Yi et al.
MOLECULAR PHARMACEUTICS (2015)
Coencapsulated Doxorubicin and Bromotetrandrine Lipid Nanoemulsions in Reversing Multidrug Resistance in Breast Cancer in Vitro and in Vivo
Xi Cao et al.
MOLECULAR PHARMACEUTICS (2015)
Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway
Li Wei et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2014)
Mechanistic Studies of a Novel Mycophenolic Acid-Glucosamine Conjugate That Attenuates Renal Ischemia/Reperfusion Injury in Rat
Xiaohong Wang et al.
MOLECULAR PHARMACEUTICS (2014)
Targeting Therapeutics to the Glomerulus With Nanoparticles
Jonathan E. Zuckerman et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2013)
Preparation, characterization, and assessment of the antiglioma effects of liposomal celastrol
Yulun Huang et al.
ANTI-CANCER DRUGS (2012)
Alanine Aminotransferase: A Clinical and Regulatory Tool for Detecting Liver Injury-Past, Present, and Future
J. R. Senior
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Drug targeting to the diseased liver
Klaas Poelstra et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Treatment of IgA Nephropathy: An Update
Jennifer L. Rosselli et al.
ANNALS OF PHARMACOTHERAPY (2011)
Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer
Radhamani Kannaiyan et al.
CANCER LETTERS (2011)
Toxic effects of celastrol on embryonic development of zebrafish (Danio rerio)
Sifeng Wang et al.
DRUG AND CHEMICAL TOXICOLOGY (2011)
Nanotechnology for therapy and imaging of liver diseases
L. Harivardhan Reddy et al.
JOURNAL OF HEPATOLOGY (2011)
Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies
Tore-Geir Iversen et al.
NANO TODAY (2011)
Targeting kidney mesangium by nanoparticles of defined size
Chung Hang J. Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mesangial pathology in glomerular disease: targets for therapeutic intervention
Yogesh M. Scindia et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Meta-Analysis of Tripterygium Wilfordii Hook F in the Immunosuppressive Treatment of IgA Nephropathy
Yi-Zhi Chen et al.
INTERNAL MEDICINE (2010)
siRNA-Based Therapy Ameliorates Glomerulonephritis
Hideki Shimizu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology
Laurent Bellest et al.
HEPATOLOGY (2007)
Liver function tests and their interpretation
B. R. Thapa et al.
INDIAN JOURNAL OF PEDIATRICS (2007)
Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways
Ying-Cheng Chen et al.
BIOCHEMICAL PHARMACOLOGY (2007)
A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results
SR Popielarski et al.
BIOCONJUGATE CHEMISTRY (2005)
Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril
S Krämer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
AASLD position paper: The management of acute liver failure
J Polson et al.
HEPATOLOGY (2005)
Uninephrectomy induces progressive glomerulosclerosis and apoptosis in anti-Thy1 glomerulonephritis
N Sakai et al.
PATHOLOGY INTERNATIONAL (2005)
Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis
J Rejman et al.
BIOCHEMICAL JOURNAL (2004)
Heterogeneity of macrophage activation in anti-thy-1.1 nephritis
AWM Minto et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis
AR Kitching et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
